NIH Grants $2 million to Symbiotix to Advance Treatment for IBD
News
The National Institutes of Health’s (NIH) National Institute of Diabetes and Digestive and Kidney Diseases recently granted Symbiotix Biotherapies $2 million to support research and of development of Polysaccharide A ... Read more